1. Home
  2. VIR vs ERII Comparison

VIR vs ERII Comparison

Compare VIR & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ERII
  • Stock Information
  • Founded
  • VIR 2016
  • ERII 1992
  • Country
  • VIR United States
  • ERII United States
  • Employees
  • VIR N/A
  • ERII N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ERII Industrial Machinery/Components
  • Sector
  • VIR Health Care
  • ERII Technology
  • Exchange
  • VIR Nasdaq
  • ERII Nasdaq
  • Market Cap
  • VIR 1.0B
  • ERII 848.7M
  • IPO Year
  • VIR 2019
  • ERII 2008
  • Fundamental
  • Price
  • VIR $7.12
  • ERII $15.80
  • Analyst Decision
  • VIR Buy
  • ERII Strong Buy
  • Analyst Count
  • VIR 5
  • ERII 3
  • Target Price
  • VIR $36.40
  • ERII $20.33
  • AVG Volume (30 Days)
  • VIR 1.6M
  • ERII 704.4K
  • Earning Date
  • VIR 10-31-2024
  • ERII 10-30-2024
  • Dividend Yield
  • VIR N/A
  • ERII N/A
  • EPS Growth
  • VIR N/A
  • ERII 22.95
  • EPS
  • VIR N/A
  • ERII 0.33
  • Revenue
  • VIR $78,618,000.00
  • ERII $135,062,000.00
  • Revenue This Year
  • VIR N/A
  • ERII $16.61
  • Revenue Next Year
  • VIR N/A
  • ERII $18.08
  • P/E Ratio
  • VIR N/A
  • ERII $47.65
  • Revenue Growth
  • VIR N/A
  • ERII 19.05
  • 52 Week Low
  • VIR $6.56
  • ERII $12.26
  • 52 Week High
  • VIR $13.09
  • ERII $20.27
  • Technical
  • Relative Strength Index (RSI)
  • VIR 38.72
  • ERII 35.75
  • Support Level
  • VIR $6.56
  • ERII $14.96
  • Resistance Level
  • VIR $10.13
  • ERII $20.27
  • Average True Range (ATR)
  • VIR 0.56
  • ERII 0.89
  • MACD
  • VIR -0.29
  • ERII -0.46
  • Stochastic Oscillator
  • VIR 14.43
  • ERII 22.93

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ERII Energy Recovery Inc.

Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.

Share on Social Networks: